These final results, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two guidance the concept of targeting ACKR3 as a unique strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-connected disorders. This overall health nutritional https://laurad294ari9.loginblogin.com/profile